Danielle Campbell
Human Resources Officer bij ATYR PHARMA, INC.
Actieve functies van Danielle Campbell
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ATYR PHARMA, INC. | Human Resources Officer | 24-12-2021 | - |
Loopbaan van Danielle Campbell
Eerdere bekende functies van Danielle Campbell
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
POSEIDA THERAPEUTICS, INC. | Human Resources Officer | 01-01-2016 | 01-01-2019 |
Corporate Officer/Principal | 01-01-2019 | 01-01-2021 | |
ATYR PHARMA, INC. | Human Resources Officer | 01-11-2015 | 01-06-2016 |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Human Resources Officer | 01-09-2014 | 01-11-2015 |
Cytori Therapeutics, Inc.
Cytori Therapeutics, Inc. BiotechnologyHealth Technology Cytori Therapeutics, Inc. develops treatments and devices for cell therapy. The private company is based in San Diego, CA. | Human Resources Officer | 01-04-2008 | 01-09-2014 |
Opleiding van Danielle Campbell
University of California, Irvine | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Operationeel
Human Resources Officer | 5 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ATYR PHARMA, INC. | Health Technology |
POSEIDA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Health Technology |
Cytori Therapeutics, Inc.
Cytori Therapeutics, Inc. BiotechnologyHealth Technology Cytori Therapeutics, Inc. develops treatments and devices for cell therapy. The private company is based in San Diego, CA. | Health Technology |
- Beurs
- Insiders
- Danielle Campbell
- Ervaring